<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12(7)</volume><submitter>Luo Y</submitter><funding>Sanofi</funding><pubmed_abstract>&lt;h4>Introduction&lt;/h4>China has the world's largest diabetes epidemic and has been facing a serious shortage of primary care providers for chronic diseases including diabetes. To help primary care physicians follow guidelines and mitigate the workload in primary care communities in China, we developed a guideline-based decision tree. This study aimed to validate it at 3 months with real-world data.&lt;h4>Methods&lt;/h4>The decision tree was developed based on the 2017 Chinese Type 2 Diabetes (T2DM) guideline and 2018 guideline for primary care. It was validated with the data from two registry studies: the NEW2D and ORBIT studies. Patients' data were divided into two groups: the compliance and non-compliance group, depending on whether the physician's prescription was consistent with the decision </pubmed_abstract><journal>Diabetes therapy : research, treatment and education of diabetes and related disorders</journal><pagination>1887-1899</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8266924</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>A Guideline-Based Decision Tree Achieves Better Glucose Control with Less Hypoglycemia at 3 Months in Chinese Diabetic Patients.</pubmed_title><pmcid>PMC8266924</pmcid><pubmed_authors>Yin H</pubmed_authors><pubmed_authors>Cui N</pubmed_authors><pubmed_authors>Huang Y</pubmed_authors><pubmed_authors>Liao X</pubmed_authors><pubmed_authors>Zhang X</pubmed_authors><pubmed_authors>Ji L</pubmed_authors><pubmed_authors>Luo Y</pubmed_authors><pubmed_authors>Li A</pubmed_authors><pubmed_authors>Zhao T</pubmed_authors><pubmed_authors>Sun X</pubmed_authors><pubmed_authors>Wu H</pubmed_authors><pubmed_authors>Zhang P</pubmed_authors></additional><is_claimable>false</is_claimable><name>A Guideline-Based Decision Tree Achieves Better Glucose Control with Less Hypoglycemia at 3 Months in Chinese Diabetic Patients.</name><description>&lt;h4>Introduction&lt;/h4>China has the world's largest diabetes epidemic and has been facing a serious shortage of primary care providers for chronic diseases including diabetes. To help primary care physicians follow guidelines and mitigate the workload in primary care communities in China, we developed a guideline-based decision tree. This study aimed to validate it at 3 months with real-world data.&lt;h4>Methods&lt;/h4>The decision tree was developed based on the 2017 Chinese Type 2 Diabetes (T2DM) guideline and 2018 guideline for primary care. It was validated with the data from two registry studies: the NEW2D and ORBIT studies. Patients' data were divided into two groups: the compliance and non-compliance group, depending on whether the physician's prescription was consistent with the decision </description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Jul</publication><modification>2026-05-08T07:47:37.952Z</modification><creation>2022-02-10T21:37:58.267Z</creation></dates><accession>S-EPMC8266924</accession><cross_references><pubmed>34050897</pubmed><doi>10.1007/s13300-021-01075-1</doi></cross_references></HashMap>